Stridebio

Developer of AAV based gene therapies for rare diseases

placeDurham, North Carolina, United States calendar_todayFounded 2015 groups109 employees language stridebio.com

Registered entities

Innovation

12 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 889 times.

YearFilings
20193
20205
20217
20227
20234
20242
20251

Investor mix

13 investors on record; lead investors include Novo Holdings, Hatteras Venture Partners, Northpond Ventures.

Investor typeCountShare
Venture capital862%
Other / undisclosed538%
Coming soon